Mane expands citrus innovation with Cvista purchase
Mane boosts citrus innovation with the purchase of Cvista, a Florida‑based producer of citrus essential‑oil fractions. The deal adds a U.S. operation to the French fragrance and flavor group’s portfolio, giving it direct access to advanced fractionation technology and closer ties to key citrus‑growing areas.
Acquisition adds new capabilities
Founded in 2010 by Hadi Lashkajani, Cvista has built a reputation for turning orange, lemon, lime and grapefruit oils into premium natural ingredients. The company supplies roughly 130 customers worldwide, ranging from perfume houses to beverage makers.
According to the filing, Mane will keep Cvista’s R&D labs, pilot plant and production lines in Riverview, Florida. The facilities are slated for expansion, with plans to broaden both research capacity and output volume.
“This acquisition represents a strategic lever for innovation in the citrus sector,” said Samantha Mane, President of the Mane Group. She added that combining the two firms’ expertise should speed the creation of high‑value citrus ingredients backed by scientific knowledge.
Florida becomes a new citrus hub
The Riverview site will be transformed into a global center of excellence for citrus. By situating operations near one of the United States’ main citrus‑growing regions, Mane hopes to shorten supply chains and improve responsiveness to market trends.
In addition, the Florida location gives Mane strategic proximity to one of the United States’ key citrus‑growing regions. The move aligns with the company’s broader push to develop next‑generation citrus ingredients for fragrances and beverages.
The hub will support Mane’s recent partnership with Arzeda, a computational‑biology pioneer working on the ViaLeaf Reb M sweetener. Cvista’s skill in isolating rare citrus molecules such as valencene, decanal and nootkatone is expected to broaden the partnership’s reach beyond beverages.
Rare molecules like valencene contribute depth and freshness to fragrance formulas, and decanal and nootkatone are prized for their distinctive scent profiles. These compounds are increasingly sought after as perfume houses look for unique natural materials.
From a practical standpoint, the acquisition could mean faster delivery of specialized citrus extracts to formulators, reducing the time needed to source and test new ingredients. Smaller fragrance studios may find it easier to obtain niche notes without long‑lead‑time orders.
Mane now operates 54 R&D centers, 31 production sites and employs more than 8,500 people across 41 countries. The company’s footprint spans Europe, Asia, the Americas and Africa, reflecting a truly global presence.
The investment mirrors a broader industry trend toward securing advanced citrus capabilities. In 2025, International Flavors & Fragrances announced a partnership with Florida Polytechnic University to open a Citrus Innovation Center in Lakeland, showing growing competition.
Industry observers note that natural‑ingredient demand is rising across both perfume and food‑and‑beverage sectors. As consumers favor cleaner labels, companies are racing to lock in sources of high‑purity, sustainably produced aromatics.
Regulatory frameworks in the United States and Europe increasingly favor natural extracts over synthetic alternatives, adding pressure on firms to demonstrate traceability and sustainability. Cvista’s established sourcing network may help Mane meet these expectations.
Overall, the acquisition positions Mane to respond more swiftly to market shifts, while giving it a foothold in a region renowned for its citrus output. The company’s next steps will likely involve integrating Cvista’s fractionation expertise into its broader product development pipeline.
